Medical Devices: Page 173
-
Stryker buys surgical lighting company for $190M
Photonics and intracavity lighting company Invuity is the latest acquisition in Stryker's ongoing purchasing spree.
By Rebecca Pifer • Sept. 11, 2018 -
FDA raises concerns about feeding tube misconnections
The agency is recommending hospitals and clinicians use devices with connectors that meet International Organization for Standardization requirements.
By Susan Kelly • Sept. 10, 2018 -
Explore the Trendlineâž”
Sitthiphong via Getty Images
TrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Becton Dickinson sells bioprocessing business to Thermo Fisher
Divesting the unit will allow Becton to better focus its life sciences division on disease and therapy research and clinical diagnostics.
By Susan Kelly • Sept. 10, 2018 -
Bundled payment model cuts joint replacement costs in study
The evaluation of the Comprehensive Care for Joint Replacement program, prepared for CMS, found the drop in costs was primarily due to reduced use of post-acute care institutions.
By Susan Kelly • Sept. 10, 2018 -
FDA clears new version of Baxter bone graft substitute
Johnson & Johnson's DePuy Synthes unit, Medtronic and Stryker make competing synthetic bone grafts.
By Susan Kelly • Sept. 7, 2018 -
Livongo adds continuous glucose data via Abbott's FreeStyle Libre
Gathering continuous glucose data is intended to help diabetes patients and their doctors personalize treatment and improve decisions about care.
By Susan Kelly • Sept. 7, 2018 -
As EpiPen struggles, Walgreens, Kaleo ink Auvi-Q partnership
Auvi-Q will now be offered at Walgreens' roughly 9,800 locations at no cost for commercially insured patients eligible for Kaleo's patient support programs.
By Jacob Bell • Sept. 7, 2018 -
BTG acquires Irish device maker Novate Medical
The $20 million cash deal could reach $150 million if certain business milestones are met.
By David Lim • Sept. 7, 2018 -
Boston Scientific inks $600M Augmenix buyout
The focus of the deal is a device to reduce the side effects of prostate cancer radiotherapy.
By Nick Paul Taylor • Sept. 7, 2018 -
Life science CEOs see future in technology, disruption
A KPMG survey also showed that cybersecurity remains a major pain point, with 33% of executives calling it the top risk to their organization's growth.
By Meg Bryant • Sept. 6, 2018 -
MRI-compatible cardiac rhythm implants cost hospitals $400M a year: report
The analysis questions the value of paying extra for premium cardiac rhythm management devices.
By Nick Paul Taylor • Sept. 6, 2018 -
Watchdog slams Veterans Health Administration on device sterility
GAO investigators found failings in the oversight of reusable medical equipment cleaning.
By Nick Paul Taylor • Sept. 6, 2018 -
Gottlieb: UnitedHealth, CareFirst sign onto FDA pilot aiming to speed device coverage
The FDA chief also outlined new programs including "QUiK Review" aimed at cutting review times for low-risk 510(k) submissions "by as much as 30%."
By David Lim • Sept. 5, 2018 -
Developing afib after valve implant raises risks, study finds
Just a third of patients who developed atrial fibrillation after a transcatheter aortic valve replacement procedure got oral anticoagulation medication at discharge, according to a Duke University study.
By Susan Kelly • Sept. 5, 2018 -
Aetna to cover Abbott's non-opioid pain implant Proclaim
The decision opens up a potential market of 22 million people for the neurostimulation device.
By Nick Paul Taylor • Sept. 5, 2018 -
Otsuka rolls out Abilify digital pill through Magellan network
The digital pill will cost $1,650 for a 30-day supply, which includes the wearable sensor and MyCite app, according to the company.
By Susan Kelly • Sept. 4, 2018 -
European Society of Cardiology endorses iFR in guidelines
Royal Philips obtained the technology in its 2015 acquisition of Volcano Corp.
By Susan Kelly • Sept. 4, 2018 -
UK sketches medtech future under no Brexit deal
With six weeks before a key deadline, the government seeks to ease the transition between old and new regulatory regimes but is unlikely to fully mitigate the impact.
By Nick Paul Taylor • Sept. 4, 2018 -
Deep Dive
FDA rarely uses its power to recall dangerous medical devices. Why not?
"Once products are on the market, it's almost an insurmountable threshold to get the agency to take action to pull them from the market," Public Citizen's Michael Carome said.
By Meg Bryant • Aug. 31, 2018 -
Pressure builds on HHS to issue interoperability rule
"Expansion of API coverage should be carefully profiled and tested by the vendor community before becoming a regulatory requirement," says Cerner's John Travis.
By Meg Bryant • Aug. 31, 2018 -
Stryker buys spine device maker K2M for $1.4B
The acquisition is expected to give Stryker some needed heft in the category, adding several differentiated products in faster-growth areas of the specialty.
By Susan Kelly • Aug. 31, 2018 -
Medtronic cryoballoon reduces persistent afib symptoms in study
The ablation device uses cold energy to interrupt irregular electrical signals in the heart in a minimally invasive procedure.
By Susan Kelly • Aug. 31, 2018 -
Philips licenses Air Force mobile patient monitoring technology
The Andover, Massachusetts-based medtech giant plans to leverage the wearable system for telemedicine purposes.
By Meg Bryant • Aug. 31, 2018 -
Alcon withdraws glaucoma device amid long-term safety concerns
Five-year data linked the stent to increased endothelial cell loss.
By Nick Paul Taylor • Aug. 30, 2018 -
Gottlieb hails early breakthrough device successes, plans AI benchmarks
The commissioner set out how the FDA is accelerating the development of medical devices.
By Nick Paul Taylor • Aug. 30, 2018
Previous
